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njections for vaccinations, the most common source of
iatrogenic pain in childhood,1 are administered repeatedly
to almost all Canadian children throughout infancy, childhood and adolescence.2 The pain associated with such injections is a source of distress for children, their parents and
those administering the injections. If not addressed, this pain
can lead to preprocedural anxiety in the future, needle fears
and health care avoidance behaviours, including nonadherence with vaccination schedules.3 It is estimated that up to
25% of adults have a fear of needles,4 with most fears developing in childhood.5 About 10% of the population avoids vaccination and other needle procedures because of needle fears.3
Conversely, minimizing pain during childhood vaccination
can help to prevent distress, development of needle fears and
subsequent health care avoidance behaviours, such as nonadherence with vaccination schedules. More positive experiences during vaccine injections also maintain and promote
trust in health care providers.3
In light of the prevalence of pain during vaccine injections
and the potential for substantial short-term and long-term
adverse sequelae, we identified a need for a national guidance
document to address this important public health issue.
Although the topic was covered in a previous narrative review1
and national guideline,4 neither of these documents was based
on the requisite systematic approach and rigorous guideline
development process. Moreover, additional data have been
published since the appearance of the previous documents.
Our objective was to develop a clinical practice guideline,
based on systematic reviews of the literature, as interpreted by
experts, to assist clinicians in managing procedure-related
pain and distress among children undergoing vaccine injections. The scope was limited to acute (immediate) pain and
distress at the time of vaccine injection in children 0 to 18
years of age. We did not consider the management of
delayed-onset pain occurring in the hours or days after the
injection. Health care providers and researchers often use the
term “distress” to refer to the combination of pain and anxiety

Key points
•

Vaccine injections performed in childhood are a
substantial source of distress.

•

Untreated pain can have long-term consequences
including preprocedural anxiety, hyperalgesia, needle
fears, and avoidance of health care.

•

Simple, cost-effective, evidence-based pain-relieving
strategies are available.

•

Recommendations in this guideline are based on a “3-P”
(pharmacologic, physical and psychological) approach.

or fear experienced by children before and during painful
medical procedures. For the purposes of this guideline, we
considered distress and pain together, referring to the combination as “pain.”
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Methods
Panel membership and funding
We convened an interdisciplinary guideline development
panel, the Help ELiminate Pain in KIDS (HELPinKIDS)
Team, to develop the guideline. Individual panel members
were selected to include individuals from diverse disciplines
and positions from across Canada, including organizations
involved in pediatric medicine (the Canadian Paediatric Society, Toronto Public Health) and immunization (the Canadian
Center for Vaccinology) and clinicians, policy-makers and scientists involved in pediatrics, pain, evidence-based medicine,
education, health policy, knowledge translation and methodology for guideline development. Parents were present and provided input at our stakeholder workshop in January 2008 and
participated in quantitative and qualitative interviews.6–8
All of the panel members signed competing interest forms.
We determined that the potential conflicts disclosed in the
forms did not affect our consideration of the evidence and
development of the recommendations.
Funding for the project was provided by the Canadian
Institutes of Health Research through a knowledge synthesis
grant (KRS-91783). The funding agency had no role in developing the recommendations, and its views and interests did
not influence the recommendations.
Guideline development process
The guideline development process
was based on published methods.9 We
used published scientific literature,
interviews with key informants and discussions with panel members and
stakeholder partners, including parents,
to identify 32 clinical questions for
consideration in the guideline. We subsequently reduced the number of clinical questions to 18, to reflect the evidence base.
Pain management is usually based
on a “3-P” approach, involving pharmacologic, physical and psychological
strategies. Therefore, our evidence base
encompassed all of these domains. For
the purposes of this guideline, selected
panel members performed three systematic reviews and meta-analyses, one
for each of the three domains of pain
management.10–12 We limited the evidence to randomized controlled trials
(RCTs) and studies with quasi-experimental designs. We used the Cochrane
Risk of Bias Tool to determine the
quality of included studies. We critically appraised the evidence and generated recommendations using the evidence-based methods outlined by the
Canadian Task Force on Preventive
Health Care,13 including an accompanyE844

ing level of evidence and grade for each recommendation
(Table 1).14 The recommendations were based on the strength
of the scientific evidence (i.e., study design and methodologic
quality), with consideration of the values that expert reviewers attributed to various outcomes and parents’ preferences.
In total, we evaluated 71 studies that included 8050 children. We presented and discussed draft recommendations at
an in-person meeting. We revised the recommendations to
reflect the comments of panel members, and the revised versions were disseminated electronically to the group for additional comments. We held a conference call for further discussion and confirmation of the recommendations. We used a
consensus process to arrive at the final wording for each
recommendation.
External review
We circulated the guideline to relevant experts for external
review according to the AGREE instrument (Appraisal
of Guidelines for Research and Evaluation;
www.agreetrust.org) (see Acknowledgements). Some of
these experts represented stakeholder organizations, including the Canadian Coalition for Immunization Awareness and
Promotion, the Canadian Nursing Coalition for Immunization, the Canadian Pharmacists Association, the Canadian
Psychological Association, the College of Family Physicians

Table 1: Criteria for evaluating evidence and grading recommendations*
Level or grade

Criteria

Evidence
I

Evidence from randomized controlled trial(s)

II-1

Evidence from controlled trial(s) without
randomization

II-2

Evidence from cohort or case–control analytic studies,
preferably from more than one centre or research
group

II-3

Evidence from comparisons between times or places
with or without the intervention; dramatic results in
uncontrolled experiments could be included here

III

Opinions of respected authorities, based on clinical
experience; descriptive studies or reports of expert
committees

Recommendation
A

There is good evidence to recommend the action.

B

There is fair evidence to recommend the action.

C

The existing evidence is conflicting and does not
allow making a recommendation for or against the
use of the action; however, other factors may
influence decision-making.

D

There is fair evidence to recommend against the
action.

E

There is good evidence to recommend against the
action.

I

There is insufficient evidence (in quantit y or quality
or both) to make a recommendation; however, other
factors may influence decision-making.

*Adapted, with permission, from Palda and colleagues.
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of Canada, the Nurse Practitioners’ Association of Ontario
and the Ontario Family Practice Nurses Association. In addition, three members of the Guidelines Advisory Committee,
who were not involved in the guideline development process,
independently evaluated the guideline. We discussed the
comments of all reviewers and incorporated them into the
final manuscript, as appropriate. We then finalized and
approved the guideline.

effects.16 Breastfeeding is considered a combined analgesic
intervention because several aspects of breastfeeding (e.g.,
holding the child, skin-to-skin contact, the sweet-tasting milk
and the act of sucking) may individually attenuate pain
responses.
Three RCTs17–19 and one study with quasi-experimental
design,20 including a total of 478 infants (up to 12 months of
age), were included in the systematic review.12 These studies
reported less pain for breastfed infants.

Clinical recommendations
For 14 of the 18 clinical questions, there was sufficient evidence to make a practice recommendation to reduce pain.
These recommendations have been organized into five clusters: infants, injection procedure, parent-led strategies, pharmacotherapy and psychological strategies. They are
sequenced according to the level of evidence and the grade of
the recommendation. For the remaining four clinical questions, there was insufficient evidence to make a practice
recommendation .
Several of the practice recommendations relating to the
injection procedure can be implemented immediately by health
care providers in all vaccination practice settings, as they do not
require planning or additional resources (e.g, time, supplies or
money). Examples of these easily adopted pain-relieving strategies include positioning children upright, performing intramuscular injections rapidly without prior aspiration, injecting the
most painful vaccine last when multiple vaccines are being
administered and providing tactile stimulation.
A few practice recommendations in this guideline, such as
breastfeeding or administration of sugar water (for infants)
and application of topical anesthetics and psychological interventions (for children of all ages), require some planning or
additional resources, or both, on the part of health care
providers and children and their families. Health care
providers are encouraged to discuss these additional options
with parents and children (as appropriate) and to select the
strategies best suited to individual children.
Pain relief is enhanced when individual pain-relieving
strategies are combined. Therefore, health care providers are
encouraged to use a mix of strategies to mitigate pain. Parents
can be enlisted to help combine and coordinate many of these
strategies. For instance, parents can prepare their children,
apply topical anesthetics, bring a distraction aid to the appointment, coach the child during deep breathing and hold the child.
Details regarding the clinical questions, evidence base,
recommendations and clinical considerations are provided
below.

Infants
1. Breastfeeding
Among infants undergoing vaccination, does breastfeeding
during the procedure reduce pain at the time of injection?
Background and evidence
Breastfeeding is the preferred method of feeding infants in
the first year of life15 and has been shown to have analgesic

Recommendation
To reduce pain at the time of injection, encourage breastfeeding mothers to breastfeed their infants during vaccination
(grade A recommendation, based on level I evidence).
Clinical considerations
Breastfeeding should be started before and should continue
during and after the vaccine injections, for up to several minutes after the last injection is complete. An adequate latch
must be established before the injection. This may take about
one minute. Some infants may refuse to breastfeed, and some
mothers may not wish to breastfeed during the vaccination.
Offering breast milk or formula via a bottle should not be
considered a substitute for breastfeeding as a method of
reducing pain.16
There are no reports of adverse events, such as gagging
or spitting up. Compared with the frequency of breastfeeding, vaccine injections are uncommon, and it is unlikely
that an infant will associate breastfeeding with painful
procedures.
2. Sweet-tasting solutions
Among infants undergoing vaccination, does administration
of sweet-tasting solutions reduce pain at the time of injection?
Background and evidence
Oral sweet-tasting solutions (with and without non-nutritive
sucking) are analgesic for infants.21,22 The proposed mechanism of analgesia involves release of endogenous opioids and
distraction.
Eleven trials with a total of 1452 infants and children17,23–32
were included in the systematic review.12 A meta-analysis of
data from six trials involving single or multiple vaccine injections (n = 665 infants up to 12 months of age)17,26−28,31,32 showed
that sucrose solution with or without non-nutritive sucking
reduced acute pain. One study of glucose solution30 yielded
positive results. Chewing sweetened gum was ineffective for
older children (aged 9–11 years).29 We concluded that sucrose
is an effective analgesic intervention for infants up to 12
months of age.
Despite a lack of studies directly comparing the analgesic
effects of breastfeeding and sweetening agents, we recommend sweet-tasting solutions only for infants who are not
breastfed during vaccination, for three reasons. First, breastfeeding is the preferred method of infant feeding, and we support breastfeeding. Second, breastfeeding does not incur additional cost or training for parents. Third, breastfeeding is a
combined analgesic intervention.
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Recommendation
To reduce pain at the time of injection among infants up to 12
months of age who cannot be breastfed during vaccination,
administer a sweet-tasting solution during vaccination (grade
A recommendation, based on level I evidence).
Clinical considerations
Sucrose solutions are inexpensive and simple to prepare. The
optimal dose is unknown, but the most common dose is 2 mL
of 25% strength (weight/volume). Up to 10 mL of the 25%
strength solution has been studied. One approach to preparing
a sucrose solution is to mix one packet or cube of sugar with
10 mL (two teaspoons) of water in a medicine cup. Alternatively, sucrose solutions can be obtained from some pharmacies. Place the dose in the infant’s mouth using an oral
syringe, medicine cup or pacifier a minute or two before the
injection. Prepare the sucrose solution immediately before use
and discard any unused portion. The analgesic effect of
sucrose may last for up to 10 minutes. Coughing and gagging
may occur but are relatively uncommon (≤ 5% of patients).12
Sweet-tasting solutions are indicated for the management
of painful procedures only, not for general comfort or as a
food supplement. Given that the volume and the frequency of
use are small, and given that many infants do not yet have
teeth, the risk of dental caries is negligible. Although parents
may wish to wash the infant’s mouth after the procedure, this
may be irritating to the infant and is not considered necessary.
Additional studies are required for infants over 12 months
of age to determine the upper age limit for reliable analgesia.

Injection procedure
3. Brand of vaccine
Among children undergoing vaccination, does administering
one commercial brand of a vaccine rather than another commercial brand of the same vaccine cause less pain at the time
of injection?
Background and evidence
Some vaccines marketed by different manufacturers are considered interchangeable. The pharmaceutical formulation for
each brand is unique, and the pain at the time of injection may
differ as a result of differences in pharmaceutical factors,10
such as pH, adjuvants and other excipients.
Four RCTs33–36 including 1027 children (12 months to 6
years of age) each compared two brands of measles–mumps–
rubella vaccine: Priorix (SmithKline Beecham Pharma,
GlaxoSmithKline) and M-M-R-II (Merck Frosst Canada &
Company) or RORVax (Aventis Pasteur-MSD), the equivalent of M-M-R-II. All of the studies reported less pain among
children who received the Priorix brand.
Recommendation
If more than one commercial brand of a vaccine is available, and the brands are interchangeable, inject the least
painful brand during vaccination of children, to reduce pain
at the time of injection (grade A recommendation, based on
level I evidence).
E846

Clinical considerations
Currently available evidence is limited to vaccines for
measles–mumps–rubella.10
Clinicians often do not have a choice about the brand of
vaccine they will use. Health authorities may provide more
than one product to ensure that enough vaccine is available.
Vaccine manufacturers and government agencies are encouraged to supply vaccines associated with less pain at the time
of injection.
4. Position of child
Among children undergoing vaccination, does positioning the
child in a supine position result in more pain at the time of
injection?
Background and evidence
Children may be vaccinated in various positions (lying supine,
sitting upright or being held). However, parents instinctively
pick up children when attempting to comfort them.37
The systematic review10 included four RCTs that examined
the influence of the child’s position on the pain response during vaccination.37–40 Altogether, 281 infants (from newborn to
six months of age) and children (aged four to six years) were
included. In three of the studies,38–40 lying supine resulted in
more pain than sitting upright or being held by a parent. One
of these three studies involved neonates,39 and skin-to-skin
contact with the mother was compared with lying supine in a
cot. In the only negative study,37 parents were able to pick up
their infants at any time after the injection, and it is possible
that mothers preferentially picked up infants who were more
distressed, which led to an outcome of no difference between
groups. Separately, in a recent study involving children who
were undergoing venous cannulation, children positioned
upright exhibited less distress than those lying supine.41 We
concluded that lying supine results in more pain than sitting
upright or being held by a parent. Although the exact mechanism underlying the reduction in pain associated with nonsupine positioning is unknown, it may involve a reduction in
anxiety, which in turn reduces the perception of pain.
Recommendation
To reduce pain at the time of injection, do not place children
in a supine position during vaccination (grade E recommendation, based on level I evidence).
Clinical considerations
The optimal position during vaccination is unknown. Infants
and children should be held by a parent in a position that is
most comfortable for both of them (e.g., hold a baby in a bear
hug, hold a child on the parent’s lap). One or more limbs
must remain exposed for the vaccination provider.
Infants and older children may sit on the examination
table. The risk of accidental falls is minimized by having a
parent stand against the examination table to provide support.
The child can lie down after the injection.
Excessive restraint may increase the child’s distress,41 so
parents and health care providers are encouraged to hold and
support children without using excessive force.
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5. Intramuscular injection techniques
Among children undergoing intramuscular injection of vaccine, should slow injection with aspiration be avoided to
reduce pain at the time of injection?
Background and evidence
Aspiration before intramuscular injection and slow injection
of vaccines are long-standing practices that have never been
subjected to scientific evaluation. Aspiration was initially proposed for safety reasons, to prevent penetration of blood vessels during the injection. Slow injection was recommended to
minimize pain from sudden distension of the tissues. 10
Together, aspiration and slow injection may actually add to
the pain of vaccine injections because of longer contact time
between the needle and the tissue and through lateral movement of the needle (“wiggle”) within the tissue.
At present, aspiration is not deemed necessary because the
anatomic sites recommended for vaccination are devoid of
large blood vessels.10 Recent data have also suggested that
one-third of vaccination providers do not perform aspiration
before intramuscular injection.7 A systematic search revealed
no risks or harms caused by omitting this step. The definition
of a slow injection is unclear. Some researchers have quantified “slow” as 5 to 10 s/mL. However, in clinical practice,
observed injection speeds have been faster.10
One RCT involving 113 infants aged four to six months42
that was included in the systematic review10 reported less pain
for intramuscular injection via a rapid injection technique
without aspiration (approximate total injection time of one
second for a volume of 0.5 mL) relative to a slow injection
technique with aspiration (approximate total injection time of
nine seconds). We believe that these results are generalizable
to all children because of similarities in the procedure and
how pain is processed neurologically.
Recommendation
To reduce pain at the time of injection, administer intramuscular
vaccines to children using a rapid injection technique without
aspiration (grade B recommendation, based on level I evidence).
Clinical considerations
The specific effect of each component (that is, slow injection
and aspiration) on the child’s pain response cannot be determined from current scientific evidence.
6. Order of injections
Among children receiving multiple vaccine injections at a
single vaccination visit, does injecting the most painful vaccine last decrease pain at the time of injection?
Background and evidence
At present, children routinely receive two or more vaccine
injections at each immunization visit. Because some vaccines
cause more pain than others, and because the pain may
increase with each subsequent injection,32 the order in which
vaccines of differing degrees of “painfulness” are administered may influence the overall pain response.
A single RCT evaluated the impact of varying the order of

injection of two different vaccines (Pentacel combination vaccine [Sanofi Pasteur] and Prevnar pneumococcal vaccine
[Wyeth]) injected sequentially in 120 infants two to six months
old.43 Giving the more painful vaccine (i.e., Prevnar) last
decreased the overall pain from both injections. We believe that
these results are generalizable to all children because of similarities in the procedure and how pain is processed.
Although no RCTs have been performed to examine the pain
of other vaccine pairs, we believe it is reasonable to extrapolate
these findings to other situations in which the choice of injecting
the more painful vaccine last is available. There is currently no
rationale for injecting the more painful vaccine first.
Recommendation
When administering multiple vaccine injections to children
sequentially, inject the most painful vaccine last to reduce
pain at the time of injection (grade B recommendation, based
on level I evidence).
Clinical considerations
From currently available evidence, vaccines known to be
more painful are M-M-R-II and Prevnar.10 When these are
coupled with other vaccines, they should be given last.
7. Tactile stimulation
Among children undergoing vaccination, does rubbing the
skin near the injection site before and during the procedure
result in less pain at the time of injection?
Background and evidence
Providing tactile stimulation is a cost-neutral intervention that
may reduce the sensation of pain. The proposed mechanism of
action involves the gate control theory of pain44 and the notion
that the sensation of touch competes with the sensation of pain
for transmission to the brain, thereby resulting in less pain.
This technique is often referred to as providing “white noise.”
Our systematic review10 identified one study with a quasiexperimental design, involving 66 children four to six years
old,45 which examined the effect of the vaccination provider
rubbing the skin near the injection site before and during vaccination. Rubbing the skin was associated with less pain.
Because pediatric data are limited, the panel also considered
adult studies when developing this recommendation. Consistent with the pediatric study, adult studies showed that either
rubbing or applying pressure to the injection site before injection reduced pain during the injection.46–48 We concluded that
tactile stimulation before and during injection results in less
pain. In the absence of data about tactile stimulation in young
children, and the potential that this intervention might focus the
child’s attention on the site or the procedure or that excessive
rubbing might cause discomfort, we felt that the results could
not be extrapolated to young children (up to four years of age).
Recommendation
To reduce pain at the time of injection among children four
years of age and older, offer to rub or stroke the skin near the
injection site with moderate intensity before and during vaccination (grade B recommendation, based on level II-1 evidence).
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Clinical considerations
The optimal method for rubbing (in terms of frequency,
intensity and pattern) is unknown. Rubbing should be
tailored according to the request and comfort level of the
individual child.
It is important to distinguish between stroking or rubbing
the skin near the injection site before and during injection and
rubbing the actual injection site after injection. Rubbing the
injection site after injection may increase the risk of vaccine
reactogenicity.49
Additional research is required to determine the lower age
limit for effectiveness, whether parents and vaccination
providers can apply this technique equally effectively and
whether equipment can be used to provide tactile stimulation,
freeing health care providers to focus on other aspects of the
vaccination process.

Parent-led interventions
8. Distraction and coaching
Among children undergoing immunization, does use of (1)
parent-led distraction or (2) parent coaching result in less pain
and pain-related distress at the time of injection?
Background and evidence
Parent-led distraction: Distraction is defined as the use of
strategies to take an individual’s attention away from the procedure. There may be differences in the effectiveness of distraction related to the individual performing the intervention.
Therefore, we examined the effectiveness of distraction performed by different operators.
Distraction that is directed or facilitated by the parent is
referred to as parent-led distraction. Parent-led distraction
typically involves prior parental training in how to deliver
age-appropriate distraction strategies. Our systematic review11
included four RCTs that examined parent-led distraction in
324 children aged one month to seven years.50–53 A metaanalysis of these studies showed that there is insufficient evidence to conclude that they reduce pain associated with vaccine injections. No differences were observed in children’s
self-reported pain, children’s pain as rated by a researcher or
children’s distress as reported by a nurse or a parent. However, the intervention had efficacy in reducing researcherrated child distress.
Parent coaching: Certain types of parental behaviours
(e.g., nonprocedural talk, suggestions on how to cope,
humour) have been related to decreases in children’s distress
and pain, whereas others (e.g., reassurance, apologies) have
been related to increases in children’s distress and pain.3 Parent coaching involves prior training in distraction combined
with appropriate parental behaviours. The two RCTs51,54 and
one study with quasi-experimental design55 included in our
systematic review,11 with a total of 212 children aged two
months to two years, yielded insufficient evidence to support
parent coaching as a strategy to reduce pain. There were no
differences in researcher-rated child pain or parent-rated child
distress. However, the intervention had efficacy in reducing
researcher-rated child distress.
E848

The lack of consistent benefit from parent-led distraction
and parent coaching in terms of pain outcomes could be due to
inadequate parental training or parents’ difficulty administering these interventions when they are themselves distressed.
The panel has recommended that clinicians discuss these interventions with parents on the following grounds. First, parents
are usually present during children’s medical procedures and
want to be involved with their children’s care.56 Second, giving
parents a formal role in psychological aspects of pain management may give them a sense of control and improve their satisfaction with the vaccination experience. Third, research has
shown some benefits of these measures on general painrelated distress. Finally, there may be limited availability of
other individuals to deliver such interventions.
Recommendation
Although there is insufficient evidence for or against the use
of parent-led distraction or parent coaching during vaccination of children as a way to reduce pain at the time of injection, clinicians may offer this intervention to parents to reduce
pain-related distress (grade B recommendation, based on
level I evidence).
Clinical considerations
Education of parents (written, electronic or in person) is
required before the use of parent-led distraction and parental
behaviours that promote the child’s ability to cope. Parents
are usually trained just before the procedure, but pamphlets
and instruction may be disseminated at a prior clinic appointment (see Appendix 1, available at www.cmaj.ca/cgi/content
/full/cmaj.101720/DC1 for sample information sheet).
Parent-led distraction should not be considered equivalent to
clinician-led distraction or child-led distraction in terms of
reducing pain. Parents may choose to offer video or television as
a distraction, but for children under two years of age, the use of
these devices is indicated as a distraction strategy only for the
management of painful procedures, not for general home use.
Additional research is required to determine the impact of
different methods of parental training, including allowing parents (and children, when appropriate) to choose the distraction modality that will be used.

Pharmacotherapy
9. Topical anesthetics
Among children receiving intramuscular and subcutaneous
injection of vaccines, does application of topical anesthetics on
the skin before the injection reduce pain at the time of injection?
Background and evidence
Topical anesthetics reduce pain associated with needle procedures, including venipuncture and intravenous cannulation.57 Our systematic review12 included 10 trials that evaluated the effects of topical anesthetics in a total of 1156 infants
and children (up to 15 years of age).17,58–66 Of the seven studies
that compared topical anesthetics with placebo cream or
patch, six showed that these drugs were effective in reducing
pain.58–63 In the negative study,64 older children (11–15 years)
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were enrolled. In addition, there were certain methodologic
limitations that might explain the results, including use of an
insensitive pain assessment method and rating of pain performed with the help of the physician. In two trials that
included a no-treatment (control) group,65,66 topical anesthetics
were ineffective, and in another trial, they were effective.17
Again, these results might be explained by some methodologic limitations, including lack of blinding and nurses’ interactions with the no-treatment (control) group, which equalized responses between the groups; increased anticipatory
anxiety because of a one-hour application time; and close
proximity of peers (children from the same classroom) influencing self-reported pain ratings. We concluded that topical
anesthetics are effective for reducing vaccination pain. We
found no evidence of interference with vaccine immunogenicity for measles–mumps–rubella vaccine or the vaccines
for diphtheria, tetanus, acellular pertussis, poliovirus, Hemophilus influenzae type B and hepatitis B.59–61

Transient changes in skin colour and sensation are common with the use of topical anesthetics, occurring in up to
one-third to one-half of individuals. Monitor the skin for
allergic reactions. Topical anesthetics are considered safe for
children of all ages. However, administration of excessive
doses and/or prolonged application times can lead to serious
adverse effects, including irregular heartbeat, seizures and difficulty breathing (see Health Canada advisory www.hc-sc.gc.ca
/dhp-mps/medeff/advisories-avis/public/_2009/emla_ametop
_pc-cp-eng.php).
In the event that the analgesic is ineffective, clinicians and
parents should consider anxiety and genetic variability as possible contributory factors.69
Although there is no evidence of interference with vaccine
immunogenicity, additional studies are recommended to rule
out an interaction between topical anesthetics and all of the
common childhood vaccines.

Psychological interventions
Recommendation
To reduce pain at the time of injection, encourage parents to
use topical anesthetics during vaccination of children (grade
A recommendation, based on level I evidence).
Clinical considerations
Topical anesthetics are available without a prescription. Topical
anesthetics currently available for sale in Canada are lidocaine–
prilocaine 5% cream or patch (EMLA, AstraZeneca Canada),
amethocaine 4% gel (Ametop, Smith and Nephew) and liposomal lidocaine 4% cream (Maxilene, RGR Pharma).
Education of parents (written, electronic or in person) is
required, including specifying the exact site or sites of administration. Topical anesthetics must be applied ahead of time,
20–60 minutes before the injection, depending on the commercial product being applied. The topical anesthetic can be
applied upon arrival at the clinic or school (by a parent or a
qualified health care professional or delegate) or before
departure from home. If multiple vaccines are being injected
during the same visit, the topical anesthetic can be applied at
two separate sites (e.g., right and left legs). The vaccine or
vaccines must be injected where the anesthetic has been
applied. Health care providers can use a nontoxic marker to
outline the area of application. The cost per dose is $5–$10.
Cream or gel preparations must be covered with a dressing
so that they are not accidentally wiped off the skin or
ingested. One approach is to apply the medication directly on
the sticky side of the dressing, flip the dressing over and then
attach it to the body location where the injection is planned,
firmly pressing the edges so that the cream does not leak out.
When removing the dressing, stretch it out and then lift it,
instead of just pulling it off. Pulling off a dressing is like
pulling off an adhesive bandage and may cause some discomfort to the child.
Previous studies have shown that parents are willing to
accommodate the administration of topical anesthetics into their
schedules, are willing to pay to reduce vaccination pain and are
able to apply topical anesthetics to their children’s skin before
needle procedures if instructed on how to do so.7,8,62,67,68

10. Clinician-led distraction
Among children undergoing vaccination, does use of clinician-led distraction result in less pain at the time of injection?
Background and evidence
Distraction has been shown to reduce children’s pain and distress from medical procedures.70,71 Distraction is defined as the
use of strategies to take an individual’s attention away from the
procedure. Distraction that is directed or facilitated by the clinician is referred to as clinician-led distraction. Our systematic
review11 included one RCT65 and three studies with quasi-experimental design,66,72,73 involving 284 children aged two months to
11 years, that examined the effect of nurse-led distraction, concluding that this form of distraction reduced pain.
Recommendation
To reduce pain at the time of injection, use clinician-led distraction techniques during vaccination of children (grade B
recommendation, based on level I evidence).
Clinical considerations
Distraction is the only psychological intervention examined in
this guideline that can be employed for children of all ages.
Some basic equipment can either be made available by the clinic
or brought by the child and family. If clinic toys are employed as
distraction strategies, they must be cleaned between uses.
Distraction strategies are relatively simple to use. The clinician who is injecting the vaccine can employ these techniques — there is no need to involve additional individuals.
However, prior training is recommended. Research studies
have typically used a one-time, 15-minute training program.
Appendix 2, available at www.cmaj.ca/cgi /content /full
/cmaj.101720/DC1, provides a summary of the key elements
for training on the use of distraction.
11. Child-led distraction
Among children undergoing vaccination, does use of childled distraction result in less pain at the time of injection?
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Background and evidence
Child-led distraction involves the use of distraction techniques by children without the aid or direction of an adult.
Our systematic review,11 which included three RCTs involving 241 children aged four to six years old,74–76 concluded that
child-led distraction is effective. We believe that these results
can be extrapolated to children three years of age and older
because of corroborating evidence from other analyses.70,71
Recommendation
To reduce pain at the time of injection among children three
years of age and older, use child-led distraction techniques
during vaccination (grade B recommendation, based on level
I evidence).
Clinical considerations
Examples of age-appropriate distraction strategies and a summary of the key elements for training on the use of distraction
are described in Appendices 1 and 2, available at www.cmaj
.ca/cgi/content/full/cmaj.101720/DC1. If appropriate, involve
children in the selection of the distraction strategy to be used.
Additional studies are needed to determine whether certain
types of stimuli (audio, visual or audiovisual) are more effective for children of different age groups and to determine the
impact of self-selection of distraction strategies.
12. Breathing techniques
Among children undergoing vaccination, does slow, deep
breathing or blowing performed by the child result in less
pain at the time of injection?
Background and evidence
Slow, deep breathing exercises serve as a relaxation strategy.
If facilitated by toys or activities (e.g., blowing bubbles),
they also serve as a distraction by focusing attention away
from the procedure. Two RCTs77,78 and two studies with
quasi-experimental design45,79 included in the systematic
review11 evaluated deep breathing in 241 children three to
seven years old. Pain was reduced if the children used
breathing exercises.
Recommendation
To reduce pain at the time of injection, have children three
years of age and older engage in slow, deep breathing or
blowing during vaccination (grade B recommendation, based
on level I evidence).
Clinical considerations
Breathing exercises make use of inexpensive and accessible
items that can easily be made available in vaccination settings. Slow, deep breathing or blowing is facilitated by distracting toys and activities (e.g., bubbles, party blowers, pinwheels). The specific impact of each component (that is, slow
deep breathing and distraction) on children’s pain response
cannot be determined from current scientific evidence.
Instruct the child to take a deep breath in and then blow it
out slowly (“tummy breathing”). Remind or prompt the child
during the procedure.
E850

13. Combined psychological interventions
Among children undergoing vaccination, does use of combined psychological interventions (i.e., interventions that
include at least one cognitive and one behavioural intervention) result in less pain and distress at the time of injection?
Background and evidence
For the purposes of the systematic review11 and this guideline,
combined psychological interventions were defined as the use
of at least two psychological interventions, one of which was
cognitive in nature and the other behavioural. Two RCTs75,80
and two studies with quasi-experimental design72,81 included in
the systematic review11 examined the effects of combined
psychological interventions in 302 children aged three to six
years. The systematic review11 concluded that these interventions were effective in reducing pain.
Recommendation
To reduce pain at the time of injection among children three
years of age and older, use combined psychological interventions during vaccination (grade B recommendation, based on
level I evidence).
Clinical considerations
Depending on the child’s cognitive maturity, some of the
combined psychological interventions may not be suitable.
For example, imagery is a complex intervention unsuitable
for young children. Some combined psychological interventions involve substantial amounts of time and cost related to
training, purchase of aids and implementation (e.g., video
instruction and modelling or practice).
14. Simple suggestions that “it won’t hurt”
Among children undergoing vaccination, does suggesting that
“it won’t hurt” result in less pain at the time of injection?
Background and evidence
Suggestion therapy is a psychological modality that typically
involves inducing the patient into a relaxed state and then
using words and intonation to produce a desired effect or alternative behaviours. Successful application of this approach
depends on first ensuring a relaxed state. In vaccination trials,
simple suggestion (brief use of words or intonation without
first inducing relaxation) has been examined for its effect on
pain associated with the injection. Two RCTs conducted in
160 children four to six years old75,82 were included in the systematic review,11 and there was no observed benefit. This
approach also raises ethical concerns because it involves
deception, which may lead to children and their families losing
trust in health care providers. The lack of demonstrated effectiveness, combined with the unethical nature of deception, led
the panel to recommend against this intervention.
Recommendation
Do not tell children that “it won’t hurt,” as this type of statement, when used alone, has been shown to be ineffective in
reducing pain at the time of injection (grade D recommendation, based on level I evidence).
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15. Skin-cooling techniques
Among children undergoing vaccination, does (1) application
of a vapocoolant spray or (2) application of ice or a cool/cold
pack on the skin before injection of vaccine reduce pain at the
time of injection?
Background and evidence
Vapocoolants: Vapocoolants (skin refrigerants) contain
chemicals that produce an instantaneous cooling effect upon
contact with the skin. The coldness may, in turn, reduce the
sensation of pain during the vaccine injections.
Four RCTs82–85 included in the systematic review10 examined the use of vapocoolants in 247 infants and children. In
three of the RCTs,82,83,85 the effect of a vapocoolant was compared with that of a placebo spray. A meta-analysis of data
from two of these RCTs (100 children aged four to six
years)82,83 showed a beneficial effect on self-reported pain. In
the third RCT, which involved 60 infants aged two to six
months, there was no difference in the pain associated with
vaccine injection.85 In two RCTs that compared vapocoolant
spray with typical care (no spray or typical care by the nurse),
there was no difference between groups,83,84 although in the
absence of a placebo group, positive results would be
expected. This result reinforced the overall negative findings.
Ice or cool/cold packs: Applying ice or cool/cold packs to
the skin produces a cooling sensation that may reduce the
sensation of pain during vaccine injections. Cool/cold packs
are readily available and inexpensive. However, two RCTs
involving 78 children aged 4 to 18 years86,87 that were included
in the systematic review10 showed that ice had no benefit.
On the basis of the results of the systematic reviews,10,12 we
concluded that there was insufficient evidence to recommend
for or against skin-cooling techniques (i.e., vapocoolants, ice,
cool/cold packs) to reduce pain in children undergoing vaccine injections. The evidence for vapocoolants contrasts with
the results of two studies performed in adults undergoing vaccine injections.48,88 It is possible that children, especially
young children (up to three years old) may perceive coldness
as painful, or the cold may cause them to focus their attention
on the procedure. Alternatively, the lack of a positive effect
might be related to inappropriate application techniques.
Recommendation
For children undergoing vaccination, there is insufficient evidence for or against the use of skin-cooling techniques
(vapocoolants, ice, cool/cold packs) to reduce pain at the time
of injection (grade I recommendation, based on conflicting
level I evidence).
Clinical considerations
Further research is needed to confirm or refute the effectiveness
of skin-cooling techniques, particularly for children six years of
age and older. Vapocoolants currently available in Canada
include ethyl chloride (Gebauer) and the combination of
1,1,1,3,3-pentafluoropropane and 1,1,1,2-tetrafluoroethane
(Pain Ease, Gebauer). The product should be sprayed on the

injection site immediately before the procedure (within one
minute of injection). The cost of Pain Ease is about $60 for 50
to 60 applications.
16. Multiple injections
Among children undergoing vaccination, does simultaneous injection by two vaccination providers cause less pain
at the time of injection than sequential injections by the
same provider?
Background and evidence
Multiple health care providers may be available at the same
time, allowing for simultaneous injection of two vaccines by
two providers rather than sequential injection by one
provider. In one RCT involving 46 children four to six years
old89 that was included in our systematic review10 there was no
difference between simultaneous and sequential injections.
The panel also considered the results of a separate study of
infants 9 to 12 months old, published as an abstract.90 The
results of that study were consistent with the included study.
Recommendation
For children undergoing vaccination, there is insufficient evidence for or against the use of simultaneous injections rather
than sequential injections to reduce pain at the time of injection
(grade I recommendation, based on limited and negative level I
evidence).
Clinical considerations
Child and parental preferences,89 developmental considerations and availability of vaccination providers may influence
whether this intervention is offered.
17. Routes of administration
Among children undergoing vaccination, for vaccines that
can be administered intramuscularly or subcutaneously, does
administering the vaccines intramuscularly, rather than subcutaneously, cause less pain at the time of injection?
Background and evidence
Some vaccines can be administered intramuscularly or subcutaneously, although the manufacturer’s instructions generally recommend only one route of administration. Two
RCTs91,92 and one study with quasi-experimental design,93
with a total of 817 children (14 months to 10 years), were
included in the systematic review.10 In two of the studies,91,92
no differences were observed in terms of either observerrated pain in infacts or children’s self-reported pain. In one
study, intramuscular injection caused more pain than subcutaneous injection in infants and children.93 However, the
investigators did not provide details about the injection technique used (e.g., whether the intramuscular injections were
performed with aspiration), which could have a substantial
impact on perception of pain.10
Recommendation
For children undergoing vaccination, there is insufficient evidence to recommend for or against the use of a specific route
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of administration for vaccines that can be administered intramuscularly or subcutaneously to reduce pain at the time of
injection (grade I recommendation, based on conflicting level
I evidence).

the procedure (because the child’s distress and struggling are
lessened) and faster recovery time. Many of the practice recommendations are cost-neutral to parents and the health care
system (e.g., rapid intramuscular injection without aspiration).

Clinical considerations
Vaccination providers should follow the manufacturer’s
instructions for route of administration.

Setting for vaccinations
Most of these practice recommendations can be incorporated
in many settings without adding any time to the vaccination
process (e.g., holding infants, tactile stimulation). Pain-relieving strategies that require additional time (e.g., education and
preparation, application of topical anesthetics) can be implemented ahead of time, either at home or upon arrival at the
vaccination setting, while the child is waiting to be vaccinated. Parents can be asked to pay a nominal fee to cover
the cost of analgesic interventions (e.g., topical anesthetics,
bubbles for blowing, sugar water). Alternatively, analgesic
interventions can be provided free of charge.
To date, the guideline has been piloted in an outpatient
clinic setting and a public health vaccination setting at a middle school. Feedback received suggests that the strategies are
feasible and effective, and that parents and children appreciate efforts made to reduce the children’s pain.

18. Oral analgesics
Among children undergoing vaccination, does administration
of acetaminophen or ibuprofen before the injection reduce
pain at the time of injection?
Background and evidence
Some clinicians recommend and some parents use oral analgesics (acetaminophen and ibuprofen) to reduce pain at the
time of injection.6 We identified no RCTs evaluating the analgesic effects of oral analgesics on acute pain at the time of
vaccine injection.
Recommendation
For children undergoing vaccination, there is currently no
demonstrated benefit of administering acetaminophen or
ibuprofen to reduce pain at the time of injection (grade I recommendation, based on level III evidence).
Clinical considerations
This recommendation refers to the use of acetaminophen or
ibuprofen to reduce acute pain at the time of vaccine injection. Delayed minor adverse events (i.e., occurring at some
time after the vaccination procedure) may be reduced by prophylactic use of acetaminophen. However, recent data have
indicated that this type of drug may interfere with the
immunogenicity of common childhood vaccines.94 As a result
of these data, this practice is being questioned.95

Implementation of the guideline
The information contained in this guideline is generalizable to
healthy children undergoing injection of vaccines worldwide.
We offer the following suggestions to assist in implementing
the guideline in various settings.
Context and facilitation
Organizations and health care providers involved in immunization are encouraged to adopt pain management as an integral component of the vaccination process. Supports should
be put in place to facilitate the implementation of these recommendations by health care providers.
Required resources
Some costs may be incurred by the incorporation of these recommendations into practice, because of required training of
staff, required time to practise pain management and expenditures to acquire aids (e.g., bubbles) and resources (e.g., pamphlets for parents and children). For the most part, these costs
are relatively modest and may be offset by shorter duration of
E852

Assessment and documentation of pain
Assessment and documentation of pain during vaccine
injections are important aspects of providing quality care.
These processes allow determination of the effectiveness of
analgesic strategies employed and planning for future vaccine injections.
In preverbal children, various behavioural cues signal the
presence of pain, including crying, facial grimacing and
writhing body movements. Older, verbal children (three years
or older) may express pain through similar behaviours but can
usually supplement the behaviours with a verbal report, which
is considered the primary source for pain assessment. In all
age groups, pain may be accompanied by physiologic
changes (e.g., increase in heart rate), but these are neither specific to pain nor clinically feasible and therefore are not recommended for monitoring pain in practice.
Here, we provide specific guidance regarding the method
of pain assessment for children of different ages, according to
our consensus interpretation of the vaccination literature, considering the validity and feasibility of currently available pain
assessment methods. For preverbal children and infants, adult
observers (parents, health care providers or both) are required
to assess pain. We recommend that health care providers use
one of two observational tools: the Modified Behavioural
Pain Scale96–98 (for infants up to 18 months of age) or the Face
Legs Activity Crying Consolability scale99 (for infants over 18
months of age). Parents should use a global rating scale (e.g.,
numerical rating scale or visual analogue scale). Verbal children can be asked to self-report pain100 using age-appropriate
techniques: either the Poker Chip tool101 (3 to 6 years of age),
the Faces Pain Scale — Revised102 (4 to 16 years of age) or a
numerical rating scale103,104 (9 years of age and older). We
encourage health care providers to document the strategies
used to reduce acute pain at the time of vaccine injection, as
well as the child’s pain score.
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Clinical considerations
Some judgment about the suitability and feasibility of the recommendations is required, as not all of the recommendations
will be appropriate or effective in all situations or for all children. In selecting specific pain-relieving strategies for use in a
particular situation, clinicians and parents are advised to consider the analgesic effectiveness of individual modalities, the
goals for the child, and the preferences of the child, the parents and the clinician.
Health care providers should offer pain-relieving options
to parents and children (as appropriate) when they are counselling about other aspects of immunization or well-baby and
child care, as parents and children are largely unaware of
effective pain-relieving strategies.
No single pain-relieving strategy recommended in this
guideline has been demonstrated to reliably reduce pain to
zero (i.e., to prevent pain). Clinicians are advised to combine
different pain-relieving strategies, as such combinations
improve pain relief.12 However, combining pain-relieving
strategies does not ensure pain-free injections.
Tools to support training and implementation
We developed a knowledge translation plan to facilitate dissemination and implementation of the guideline. This plan
incorporates several educational tools, including a guide to
pain management for parents and caregivers (Appendix 1), a
guide to pain management for health care providers (Appendix 2) and a tool that health care providers can use to assess
and document pain (Appendix 3) (all appendices are available at www.cmaj.ca/cgi/content/full/cmaj.101720/DC1). A
website and educational video for parents and health care
providers has also been created (available online and freely
accessible at www.sickkids.ca/Learning/SpotlightOnLearning
/profiles-in-learning/help-eliminate-pain-in-kids/index.html).
These various tools can be customized to the needs of individual practice settings. In addition, several professional
organizations (listed at the end of the article) have endorsed
or supported this guideline and will assist in its dissemination. This assistance includes online links to the guideline
and associated tools and incorporation of recommendations
in immunization resources. Educational workshops are being
offered to various stakeholder groups.
The guides for parents and health care providers are similar and include information about pain-relieving strategies
that are relevant to each user group, as well as information
about how to implement them during vaccine injections. The
documentation tool allows the health care provider to record
information about the vaccine or vaccines administered, the
child’s age, age-appropriate pain assessment techniques and
the child’s pain score. The form can be inserted into the
child’s medical chart and/or given to parents and caregivers.
The educational video demonstrates the use of pain-relieving
strategies.
Updates to the guideline
We will review feedback from users of the guideline and
determine the appropriate timing for revision and update of
the guideline.

Limitations
The recommendations included in this guideline are limited
by the evidence that was available at the time of publication
of the three systematic reviews.10–12 Certain recommendations
have more research support than others. In addition, some of
the recommendations are applicable to children of all ages,
whereas others apply only to subgroups of children.
For some pain-relieving strategies (e.g., use of sweettasting solutions, tactile stimulation), we could not determine with confidence the optimal administration technique
and the upper and/or lower age limits for effectiveness from
the existing evidence.
Some of the research studies upon which the recommendations are based were limited in terms of the inclusion of children and parents with different demographic characteristics
and backgrounds. For instance, children with cognitive
impairment or a history of traumatic needle procedures might
not have been included. We did not consider these factors in
the recommendations; however, we acknowledge that the
experience of pain may be mediated by such factors. Moreover, they may influence the pain-relieving strategies that
clinicians, parents and children choose to employ.
Our literature search did not identify studies examining
the impact on injection-related pain of the environment or
setting in which vaccination was performed (e.g., clinic,
school), characteristics of the needle and selected aspects of
the injection technique (e.g., gauge, length, angle of injection) or the body region where the vaccine was injected
(e.g., arm, thigh). We recommend that future studies examine the effect of these factors on pain at the time of vaccine
injection.
For this guideline, we did not consider complementary and
alternative medicines, and the published effectiveness of such
therapies could be included in future revisions.

Directions for future research
At present, the optimal pain-relieving regimen for nullifying
pain, rather than simply diminishing pain, is unknown. Additional research is recommended to determine which painrelieving regimens reliably prevent pain in children of different ages. New technologies for administering vaccines (e.g.,
microneedles) and needle-free administration techniques
(e.g., nasal sprays) offer alternative ways of preventing pain
for which further investigation is also required.
The impact of consistent pain management during injections of vaccines on short-term and long-term outcomes,
including the child’s pain, satisfaction with the vaccination
experience, development of needle fears and adherence with
vaccination schedules, has not been evaluated. This is clearly
an important topic for future research.
The education of all primary stakeholders involved in
childhood immunization, including parents, children and
health care providers, is fundamental to any improvements in
the delivery of vaccine injections in children. Additional
research is planned to determine the impact of the knowledge
translation interventions for this guideline.
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